TAF/EVG vaginal insert

DRUG2 trials

Sponsors

CONRAD, Eastern Virginia Medical School

Conditions

HSVHivSafety Issues

Phase 1

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

CompletedNCT03762772

Start: 2018-12-10End: 2019-03-20Updated: 2019-07-16

Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

CompletedNCT06087913

Eastern Virginia Medical SchoolSafety Issues

Start: 2023-11-08End: 2024-12-02Updated: 2025-09-02

Related Papers

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir

Frontiers in Cellular and Infection Microbiology2023-04-1911 citations